Skip to main content

FDA recall, , Moderate risk

Llorens Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement

Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement contains foreign black particulate matter.

Recall ended Sep 28, 2026. Still check yours.

What happened

Llorens Pharmaceuticals International Division, Inc., of Miami, Florida, recalled its Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement because the product contains foreign black particulate matter. The recall began on May 7, 2026, and was added to the FDA's Enforcement Report on May 19, 2026.

The product was distributed to Arizona, California, Colorado, Delaware, Florida, Georgia, Iowa, Illinois, Indiana, Massachusetts, Minnesota, Missouri, North Carolina, New Jersey, New York, Ohio, Oklahoma, Tennessee, Texas, Virginia, Washington, Wisconsin and West Virginia.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for food recalls:

  1. Return it to the store where you bought it, or throw it away.
  2. Don't give it to anyone else, such as a food bank, or to a pet.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

  1. Product details

    Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET modern round 24-400 bottle, 47 SERVING PER BOTTLE, 24 bottles- 8 FL Oz (237mL) Amber PET modern round bottles per package, Store at room. Mnfg by: Llorens Pharmaceutical Miami, FL

    Lot code
    • B2025

Recall details

Company began the recall
Company
Llorens Pharmaceuticals International Division, Inc.Miami, Florida
Risk

Moderate risk

Eating it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98958
Recall number
H-0809-2026
Quantity recalled
4,196 units

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Recall ended

  6. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 12, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)